Market closedNon-fractional
Integra LifeSciences/IART
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Integra LifeSciences
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Ticker
IART
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Princeton, United States
Employees
3,946
Website
www.integralife.com
IART Metrics
BasicAdvanced
$2.5B
Market cap
61.86
P/E ratio
$0.51
EPS
1.11
Beta
-
Dividend rate
Price and volume
Market cap
$2.5B
Beta
1.11
Financial strength
Current ratio
4.681
Quick ratio
3.062
Long term debt to equity
125.679
Total debt to equity
127.945
Interest coverage (TTM)
4.53%
Management effectiveness
Return on assets (TTM)
4.00%
Return on equity (TTM)
2.46%
Valuation
Price to earnings (TTM)
61.864
Price to revenue (TTM)
1.627
Price to book
1.55
Price to tangible book (TTM)
-5.33
Price to free cash flow (TTM)
40.852
Growth
Revenue change (TTM)
-2.07%
Earnings per share change (TTM)
-75.31%
3-year revenue growth (CAGR)
3.55%
3-year earnings per share growth (CAGR)
-36.53%
What the Analysts think about IART
Analyst Ratings
Majority rating from 14 analysts.
IART Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$369M
-7.10%
Net income
-$3.2M
-116.16%
Profit margin
-0.86%
-117.27%
IART Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.71
$0.76
$0.89
$0.55
-
Expected
$0.57
$0.78
$0.90
$0.55
$0.62
Surprise
24.76%
-2.30%
-1.46%
-0.30%
-
IART News
AllArticlesVideos
Integra LifeSciences Provides Updated Plans for Its Manufacturing Facility in Braintree, Massachusetts
GlobeNewsWire·2 weeks ago
Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
GlobeNewsWire·2 months ago
Integra LifeSciences Reports First Quarter 2024 Financial Results
GlobeNewsWire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Integra LifeSciences stock?
Integra LifeSciences (IART) has a market cap of $2.5B as of July 27, 2024.
What is the P/E ratio for Integra LifeSciences stock?
The price to earnings (P/E) ratio for Integra LifeSciences (IART) stock is 61.86 as of July 27, 2024.
Does Integra LifeSciences stock pay dividends?
No, Integra LifeSciences (IART) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Integra LifeSciences dividend payment date?
Integra LifeSciences (IART) stock does not pay dividends to its shareholders.
What is the beta indicator for Integra LifeSciences?
Integra LifeSciences (IART) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Integra LifeSciences stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.